AME profit jumps 44% to SAR 22.2 mln in H1 2023

AME profit jumps 44% to SAR 22.2 mln in H1 2023

21/08/2023 Argaam Exclusive

View other reports

AME Company for Medical Supplies reported a net profit leap of 44% to SAR 22.2 million in the first half of 2023 from SAR 15.4 million in the prior-year period.



Financials (M)

Item 6m 2022 6m 2023 Change‬
Revenues 108.35 120.34 11.1 %
Gross Income 48.86 55.69 14.0 %
Operating Income 17.25 24.01 39.2 %
Net Income 15.38 22.20 44.4 %
Average Shares 7.00 7.00 -
EPS (Riyals) 2.20 3.17 44.4 %

The higher profit was driven by a rise of SAR 11.99 million in medical equipment sales.



Current Half Annual Comparison (M)

Compared With The
Item H1 2022 H1 2023 Change‬
Revenues 108.35 120.34 11.1 %
Gross Income 48.86 55.69 14.0 %
Operating Income 17.25 24.01 39.2 %
Net Income 15.38 22.20 44.4 %
Average Shares 7.00 7.00 -
EPS (Riyals) 2.20 3.17 44.4 %

Shareholders’ equity, no minority interest, reached SAR 115.55 million as of June 30, 2023, up from SAR 96.54 million a year earlier.

 

                                                                    Historical Data

Period

Revenue

(SAR mln)

Net Profit

(SAR mln)

EPS

(SAR)

H1 2020

44.66

4.18

0.60

H2 2020

76.94

16.89

2.41

H1 2021

69.78

7.50

1.07

H2 2021

81.61

13.72

1.96

H1 2022

108.35

15.38

2.20

H2 2022

84.82

11.30

1.61

H1 2023

120.34

22.20

3.17

 

View More Financial Results

 


Financial results (Million)

Period Revenues Change Gross Income Change Operating Income Change
H1 2014 - - - - - -
H2 2014 - - - - - -
H1 2015 - - - - - -
H2 2015 - - - - - -
H1 2016 - - - - - -
H2 2016 - - - - - -
H1 2017 - - - - - -
H2 2017 - - - - - -
H1 2018 - - - - - -
H2 2018 - - - - - -
H1 2019 - - - - - -
H2 2019 - - - - - -
H1 2020 44.66 - 22.01 - 4.94 -
H2 2020 76.94 - 33.27 - 17.70 -
H1 2021 69.78 56.2 % 32.00 45.4 % 13.27 168.5 %
H2 2021 81.60 6.1 % 37.54 12.8 % 15.70 (11.3 %)
H1 2022 108.35 55.3 % 48.86 52.7 % 17.25 30.0 %
H2 2022 84.82 3.9 % 41.42 10.3 % 12.72 (19.0 %)
H1 2023 120.34 11.1 % 55.69 14.0 % 24.01 39.2 %


Profit Performance (Million)

Period Net Income Change EPS(Riyal) Extraordinary Income/Expense Net Profit Before Unusual Items EPS Before XO Items
H1 2014 - - - - - -
H2 2014 - - - - - -
H1 2015 - - - - - -
H2 2015 - - - - - -
H1 2016 - - - - - -
H2 2016 - - - - - -
H1 2017 - - - - - -
H2 2017 - - - - - -
H1 2018 - - - - - -
H2 2018 - - - - - -
H1 2019 - - - - - -
H2 2019 - - - - - -
H1 2020 4.18 - 0.60 - 4.18 0.60
H2 2020 16.89 - 2.41 - 16.89 2.41
H1 2021 7.50 79.3 % 1.07 (4.32) 11.82 1.69
H2 2021 13.72 (18.7 %) 1.96 (0.15) 13.87 1.98
H1 2022 15.38 105.1 % 2.20 - 15.38 2.20
H2 2022 11.31 (17.6 %) 1.62 - 11.31 1.62
H1 2023 22.20 44.4 % 3.17 - 22.20 3.17

Profitability

Period Gross Margin OIBDA Margin Net Margin Before Unusual Items
H1 2014 - - -
H2 2014 - - -
H1 2015 - - -
H2 2015 - - -
H1 2016 - - -
H2 2016 - - -
H1 2017 - - -
H2 2017 - - -
H1 2018 - - -
H2 2018 - - -
H1 2019 - - -
H2 2019 - - -
H1 2020 - - -
H2 2020 45.46 % 18.86 % 17.33 %
H1 2021 44.49 % 21.31 % 19.57 %
H2 2021 45.94 % 19.44 % 16.97 %
H1 2022 45.49 % 17.71 % 15.40 %
H2 2022 46.74 % 15.96 % 13.81 %
H1 2023 47.34 % 18.49 % 16.33 %


Per Share Data (Riyal)

Compared With The
Period Shares Outstanding (M) EPS (Riyal) Adjusted EPS (Riyal) Book Value (BV)
H1 2014 - - - -
H2 2014 - - - -
H1 2015 - - - -
H2 2015 - - - -
H1 2016 - - - -
H2 2016 - - - -
H1 2017 - - - -
H2 2017 - - - -
H1 2018 - - - -
H2 2018 - - - -
H1 2019 - - - -
H2 2019 - - - -
H1 2020 7.00 - - 3.20
H2 2020 7.00 3.01 3.01 9.08
H1 2021 7.00 3.48 4.10 11.72
H2 2021 7.00 3.03 3.67 13.34
H1 2022 7.00 4.16 4.18 13.79
H2 2022 7.00 3.81 3.81 15.34
H1 2023 7.00 4.79 4.79 16.51

Multiple Ratios (End of Period Price)

Compared With The
Period P/E Adjusted P/E Price/book
H1 2014 - - -
H2 2014 - - -
H1 2015 - - -
H2 2015 - - -
H1 2016 - - -
H2 2016 - - -
H1 2017 - - -
H2 2017 - - -
H1 2018 - - -
H2 2018 - - -
H1 2019 - - -
H2 2019 - - -
H1 2020 - - -
H2 2020 - - -
H1 2021 - - -
H2 2021 - - -
H1 2022 10.46 10.41 3.15
H2 2022 9.16 9.16 2.28
H1 2023 9.86 9.86 2.86

Business Segments (Million)

Compared With The
Period Medical supplies Medical equipment sales Real Estate Management Others
Q2 2020 34.27 8.38 1.86 0.15
Q4 2020 65.25 9.20 2.45 0.04
Q2 2021 51.04 15.33 3.24 0.18
Q4 2021 67.96 11.75 2.07 -
Q2 2022 83.97 21.46 2.76 0.15
Q4 2022 68.80 10.79 3.09 2.13
Q2 2023 94.68 22.95 2.52 0.18


Financial Ratios
Current
Market Cap (M Riyal) 840.00
Enterprise Value (EV) (M) 796.60
Shares Outstanding ((M)) 7.00
Book Value (BV) ( Riyal) 18.17
Par Value ( Riyal) 10.00
Adjusted P/E (Last12) 25.06
Price/book 6.61
more

Share Price

AME Company for Medical Supplies
120.00
1.40 1.18 %

AME Company for Medical Supplies (AME)

More

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.